Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients

PURPOSE: The soluble form programmed death-ligand 1 (sPDL1) has immunosuppressive properties and is being studied as a candidate biomarker for immuno-oncology drug development. We measured the serum sPDL1 at pre-and post-chemotherapy and evaluated its prognostic implication and dynamics during chemo...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Res Treat
Main Authors: Park, Woochan, Bang, Ju-Hee, Nam, Ah-Rong, Jin, Mei Hua, Seo, Hyerim, Kim, Jae-Min, Oh, Kyoung Seok, Kim, Tae-Yong, Oh, Do-Youn
פורמט: Artigo
שפה:Inglês
יצא לאור: Korean Cancer Association 2021
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812012/
https://ncbi.nlm.nih.gov/pubmed/33070562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2020.497
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים